Blockchain Pilot Project To Track Drugs from Lab to Pharmacist

June 10, 2020

Update on a blog we wrote last year about the US Food and Drug Administration (FDA) working with Merck, IBM, KPMG, and Walmart, in a pilot project aimed at evaluating the use of blockchain technology to protect the integrity of their drugs. The project, built on hyperledger fabric, was completed last December (2019). The goal of the project is to trace the journey of various vaccines and prescription medicines made by Merck from manufacture to delivery. Because the pharma supply chain is complex, given the number of entities, logistic providers and distributers – all using different systems, they fail to meet the DSCSA’s interoperability requirements. In the final report to the FDA, the partners in the pilot project agreed that blockchain could be their information bridge.

In the bigger picture, the FDA’s plan is to use a platform that can track and trace prescription medicines and vaccines distributed in the United States. The key benefits to such a platform would include: reducing the time needed to track and trace, improving access to reliable distribution information and ensuring products are handled appropriately and stored at the right temperature while being distributed.

IBM and Merck are examples of global leaders who are at the forefront of new technology and its applications. They can be found in Harvest ETF solutions. IBM is a component of the Harvest Tech Achievers Growth & Income ETF (TSX: HTA, HTA.U, HTA.B), and Merck is a component of the Harvest Healthcare Leaders Income ETF (TSX:HHL, HHL.U, HHL.B).

In the Harvest specialty Index ETF line up, the Blockchain Technologies ETF (TSX: HBLK) holds 20 stocks, as at May 29, 2020, exposed to the development and implementation of Blockchain and distributed ledger technologies. The ETF has 22 holdings, 10 core large cap holdings with an average market capitalization of CAD $4.12 Billion and 12 dedicated holdings, as at May 29, 2020 with a management fee of 0.65%.

For more information about Harvest ETFs click here.

The views and/or opinions expressed in the blog are of a general nature and are for informational purposes only. Blog contents should not be considered as advice and/or a recommendation to purchase or sell the mentioned securities or used to engage in personal investment strategies. Investors should consult their investment advisor before making any investment decision.

You may also like…

Disclaimer

You will usually pay brokerage fees to your dealer if you purchase or sell units of the Fund(s) on the TSX. If the units are purchased or sold on the TSX, investors may pay more than the current net asset value when buying units of the Fund(s) and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units of an investment fund. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents.

Certain statements in the Harvest Blog are forward looking Forward-looking statements (“FLS”) are statements that are predictive in nature, depend upon or refer to future events or conditions, or that include words such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “intend,” “plan,” “believe,” or  “estimate,” or other similar expressions. Statements that look forward in time or include anything other than historical information are subject to risks and uncertainties, and actual results, actions or events could differ materially from those set forth in the FLS.

FLS are not guarantees of future performance and are by their nature based on numerous assumptions, which include, amongst other things, that (i) the Fund can attract and maintain investors and have sufficient capital under management to effect their investment strategies, (ii) the investment strategies will produce the results intended by the portfolio managers, and (iii) the markets will react and perform in a manner consistent with the investment strategies. Although the FLS contained herein are based upon what the portfolio manager believe to be reasonable assumptions, the portfolio manager cannot assure that actual results will be consistent with these FLS.

Unless required by applicable law, Harvest Portfolios Group Inc. does not undertake, and specifically disclaim, any intention or obligation to update or revise any FLS, whether as a result of new information, future events or otherwise.

Subscribe to our newsletter and stay informed

Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *


Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *